Dr. Wolfgang Jahnke received his PhD with Prof. Horst Kessler at the Technische Universität München. He worked with Dr. Peter Wright at the ScrippWolfgang Jahnkes Research Institute in La Jolla, California, before joining Novartis in 1995. In his 20 years at Novartis, Wolfgang has pioneered the application of protein NMR spectroscopy and fragment-based approaches in drug discovery. His contributions were internally and externally recognized by the Novartis Leading Scientist award in 2002, and the Industrial Investigator Award by the Swiss Chemical Society in 2014. Wolfgang has co-authored more than 80 scientific publications and patents, is member of the executive committee of the Magnetic Resonance Section of the German Chemical Society and of the Experimental NMR conference, has co-organized the Fragment-Based Lead Discovery Conference FBLD2014 in Basel, and has co-edited two books on fragment-based lead discovery. Wolfgang is currently Director in the Structural Biophysics department and is responsible for the development and application of NMR spectroscopy and other biophysical methods for lead discovery at Novartis, especially with respect to fragment-based drug discovery.









Contact details

Please contact us at:

FRAGNET Coordinator
VU University Amsterdam
The Netherlands

Funded by

marie curie actions   Marie Curie Actions



EU Horizon 2020



european union logo   European Union